Integron Pharma Private Limited
About Integron Pharma Private Limited
Data last updated:
Integron Pharma Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 June 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2007PTC020904. Its GSTIN is 32AABCI8015R1ZC (Kerala).
The company has an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹1.26 Cr. It is led by directors including Prasad Sivadas (Managing Director) and Karuvarath Shanoj (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/492/9 1st Floor Arrackal Tower Christopher Nagar Ollur P.O, Thrissur, Kerala, India – 680306.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.36 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹40.7 Lakh (net margin 4.9%) and EBITDA of ₹56.37 Lakh (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 15% over five years.
The company has about 39 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Integron Pharma Private Limited's registered office is in Thrissur, Kerala. Its e-mail address is in the company report.
- Email
- Registered Address1/492/9 1st Floor Arrackal Tower Christopher Nagar Ollur P.O, Thrissur, Kerala, India – 680306
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Integron Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Integron Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Integron Pharma Private Limited, buy the company report.
Financials of Integron Pharma Private Limited
FY 2025 filings availableIntegron Pharma Private Limited reported revenue of ₹8.36 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 17% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Integron Pharma Private Limited, buy the company report.
Board of directors of Integron Pharma Private Limited
Integron Pharma has 7 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karuvarath Shanoj Also directs: Inots Meditech Private Limited | Whole-Time Director | 07 Jan 2011 | 15 Years 9 Months | Current |
| Jasmin Faizal Also directs: Waymed Proximus Private Limited, DF Endoklinic.In Private Limited | Director | 07 Jan 2011 | 15 Years 9 Months | Current |
| Jaya Sree Narayanan Also directs: Sukapuram Hospital Private Limited | Director | 07 Jan 2011 | 15 Years 9 Months | Current |
| Saji Kuzhi Chalil Also directs: Inots Meditech Private Limited, Sahaa Combines Holidays LLP | Whole-Time Director | 07 Jan 2011 | 15 Years 9 Months | Current |
| Prasad Sivadas Also directs: Inots Meditech Private Limited | Managing Director | 07 Jan 2011 | 15 Years 9 Months | Current |
| Thaniyan Salim Also directs: Inots Meditech Private Limited | Whole-Time Director | 08 Jun 2007 | 19 Years 4 Months | Current |
Peer comparison
Integron Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neomac Pharmaceuticals Private Limited | ₹8.43 Cr (FY 2024) | 21.0% | Amritsar, Punjab, India | |||
| Litex Pharmaceuticals Private Limited | ₹8.43 Cr (FY 2024) | 18.0% | Delhi, India | |||
| Hindustan Trust Private Limited | ₹8.42 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Herbs and Health Makers (India) Private Limited | ₹8.38 Cr (FY 2025) | 1.0% | Indore, Madhya Pradesh, India | |||
| Integron Pharma Private Limitedthis company | ₹8.36 Cr (FY 2024) | ₹40.7 Lakh | 4.9% | 17.0% | 39 | Thrissur, Kerala, India |
| CJ Bio India Private Limited | ₹8.32 Cr (FY 2025) | 61.0% | Chennai, Tamil Nadu, India | |||
| Deepar Pharmaceuticals Private Limited | ₹8.3 Cr (FY 2025) | 6.0% | Jaipur, Rajasthan, India | |||
| Pro Success Pharma & Surgical Private Limited | ₹8.3 Cr (FY 2025) | -8.0% | Pune, Maharashtra, India | |||
| Carbonium Chem Private Limited | ₹8.27 Cr (FY 2019) | 11.0% | New Delhi, Delhi, India |
To see the full peer comparison of Integron Pharma Private Limited, buy the company report.
Auditor
Integron Pharma Private Limited is audited by THOMAS TONY & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THOMAS TONY & CO | FY 2020 | 008584S |
Shareholding
The shareholding of Integron Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Integron Pharma Private Limited, buy the company report.
Legal cases
Integron Pharma Private Limited has 1 court case on record: 1 filed by Integron Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (Crl.MC) | Filed by the company against individuals | Disposed |
To see the full case history of Integron Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Integron Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Integron Pharma Private Limited has a workforce of 39 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Integron Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AABCI8015R1ZC | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Integron Pharma Private Limited, buy the company report.
Recent activity
Integron Pharma Private Limited has 13 board changes on record since 2007: 10 appointments and 3 cessations. The latest: Vishnu Prabhakar ceased to be Director on 10 Dec 2014.
4 earlier events are in the company report.
Frequently asked questions
Integron Pharma is an active private limited company based in Thrissur, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 June 2007 (19+ years old) and is registered under CIN U51397KL2007PTC020904.
Integron Pharma has 7 current directors:
- Prasad Sivadas - Managing Director
- Karuvarath Shanoj - Whole-Time Director
- Saji Kuzhi Chalil - Whole-Time Director
- Thaniyan Salim - Whole-Time Director
- Kizhakkapedika Rijo Varghese - Whole-Time Director
- Jasmin Faizal - Director
- Jaya Sree Narayanan - Director
The latest financial statements of Integron Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Integron Pharma is 32AABCI8015R1ZC, registered in Kerala.
The CIN (Corporate Identification Number) of Integron Pharma is U51397KL2007PTC020904. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Integron Pharma has 1 court case on record: 1 filed by the company.
Integron Pharma was incorporated on 08 June 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Integron Pharma by revenue are Neomac Pharmaceuticals Private Limited, Litex Pharmaceuticals Private Limited, Hindustan Trust Private Limited, Herbs and Health Makers (India) Private Limited, CJ Bio India Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Vishnu Prabhakar ceased to be Director on 10 Dec 2014. Nadutharamahal Vajid Nihas ceased to be Director on 15 Mar 2014. Thampiath Puthanveetil Shaji ceased to be Director on 01 Feb 2013. Integron Pharma has 13 board changes on record in total.
The registered office of Integron Pharma is at 14929 1st Floor Arrackal Tower Christopher Nagar Ollur P.O, Thrissur, Kerala, India – 680306.
Integron Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.